Who is sponsoring NCT06666062?

NCT06666062 is sponsored by Lina Amr Talaat.

What drugs are being tested in NCT06666062?

Interventions in NCT06666062: implant placement and low level laser therapy, implant placement.

What condition does NCT06666062 study?

NCT06666062 studies Laser Effect Around Dental Implant.

Is NCT06666062 still recruiting?

NCT06666062 is currently active, enrolled. Last updated 30 October 2024.

Last reviewed 2024-10-30 · How we verify

NCT06666062

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Effect of Low Level Laser Therapy on Crestal Bone Changes and Secondary Stability Around Delayed Implant

Active, enrolled NA Last updated 30 October 2024

What this trial tests

NA trial testing implant placement and low level laser therapy in Laser Effect Around Dental Implant in 24 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 March 2023

Primary endpoint
1 May 2024

1 December 2024

Quick facts

Lead sponsor	Lina Amr Talaat
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	24
Start date	1 March 2023
Primary completion	1 May 2024
Estimated completion	1 December 2024
Sites	1 location across Egypt

Drugs / interventions tested

implant placement and low level laser therapy
implant placement

Conditions studied

Laser Effect Around Dental Implant — all drugs for Laser Effect Around Dental Implant →

Sponsor

Lina Amr Talaat

Who can join

Adults 20 to 50, any sex, with Laser Effect Around Dental Implant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Although implant survival and success rates are prominent, there is still progress to be made in both survival and success rates, as well as in improving implant stability at implant placement in order to accomplish osseo-integration without significantly reducing peri-implant marginal bone. Low-level laser therapy (LLLT) has been postulated in studies looking into enhancing implant stability. Understanding the effect of LLLT on bone remodeling is crucial to knowing whether LLLT will enhance implant-bone interaction. LLLT prompts vascularization of the bone defect site and also stimulates osteoblasts, which can facilitate recovery of hard tissue. In addition, it has been recently reported that LLLT has positive effects in ossification and osseo-integration of dental implants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06666062 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lina Amr Talaat
Last refreshed: 30 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06666062.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing